Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Synovial × trofosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 2 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Recurrence 1 Medulloblastoma 1 Ependymoma 1 Brain Neoplasms 1

Interventions

Doxorubicin 14 Cyclophosphamide 13 Ifosfamide 9 fludarabine 8 tazemetostat 5 Radiotherapy 5 pembrolizumab 4 Gemcitabine 4 pegfilgrastim 3 pazopanib 3 cixutumumab 3 Trabectedin 3 Filgrastim 3 Docetaxel 3 sargramostim 2 fludarabine phosphate 2 brostallicin 2 X-Rays 2 Sunitinib 2 Sorafenib 2 Radiation 2 Interferon-gamma 2 Immunotherapy, Adoptive 2 Imatinib Mesylate 2 Dacarbazine 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 trofosfamide 1 tremelimumab 1 temsirolimus 1 sotigalimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00876031 2022-11-08

CWS-2007-HR

University Hospital Tuebingen

Phase 3 Completed

Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡